Key points are not available for this paper at this time.
Design
Letter to the editor
Answers are grounded in this paper and cite their sources.
Platelet indices may associate with RAS mutations in colon cancer; leaves open any added prognostic or predictive value.
I read with interest the formerly published paper entitled “Retrospective evaluation of platelet indices and RAS mutations in patients with colon cancer” by Şanlıer et al. (1). In that published paper, the authors evaluated the hematological indices in colon cancer patients and their relationships between RAS mutations. It has been noticed that the authors evaluated neutrophil to lymphocyte ratio (NLR), mean platelet volume (MPV), platelet to lymphocyte ratio (PLR) and red cell distribution width (RDW) as hematological indices in colon cancer cases. I would like to thank the authors for valuable contribution to the literature for especially topic on colon cancer.
No takes yet. Share an insight, caveat, or question.
Kemalettin Yılmaz (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: